Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
5-Bromocytidine protects against hyperuricemia-induced renal injury by suppressing TLR4/NF-κB-mediated inflammation (2026-04-09)
Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2026) IF: 4.7Products Cited: -
Artesunate reverses gefitinib resistance in lung adenocarcinoma by inducing ferroptosis and suppressing the Wnt/β-catenin pathway (2026-04-10)
Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2026) IF: 4.7Products Cited: -
Design, synthesis, formulation, and bioevaluation of ZZP-2, a FLT3-ITD inhibitor for the treatment of acute myeloid leukemia (2026-01-09)
Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2026) IF: 4.7Products Cited: Penicillin-Streptomycin Solution, 100 ×, Puromycin（10 mg/mL） -
89Zr/177Lu-Labeled Claudin-6 Antibody Exhibits Effective Targeted Radiodiagnostic and Therapeutic Efficacy in Gynecological Cancers (2026-02-27)
Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2026) IF: 4.7Products Cited: A2780 Cells Line -
PET/CT imaging of the peptide-based anti-CD47 probe [18F]AlF-NOTA-Pep-20 in preclinical models (2026-04-11)
Journal: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2026) IF: 4.7Products Cited: -
Valorization of flaxseed Cyclolinopeptides from byproduct: Optimization of extraction and evaluation of cellular protective effects (2026-02-26)
Journal: Food Chemistry: Molecular Sciences (2026) IF: 4.7Products Cited: Human Dermal Fibroblasts -
Integrating single-cell and bulk RNA sequencing to identify disulfidptosis-related gene signature, immune landscape, and immunotherapy targets in cutaneous melanoma (2026-01-06)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2026) IF: 4.7Products Cited: DMEM (Glucose free) Medium -
Monocrotaline induces liver injury via TRX1-ASK1-JNK Axis-mediated mitochondrial damage in hepatocytes (2026-01-09)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2026) IF: 4.7Products Cited: -
Multi-omics profiling reveals that targeting NEK3 synergizes with cuproptosis to promote M1 macrophage polarization in cervical cancer (2026-01-02)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2026) IF: 4.7Products Cited: Human Cervical Cancer Tissue-Derived Cells -
Tucidinostat ameliorates DSS-induced ulcerative colitis by inhibiting cellular senescence, modulating the p53 signaling pathway and cell cycle, and restoring the gut microbiota-metabolite Axis (2026-01-03)
Journal: INTERNATIONAL IMMUNOPHARMACOLOGY (2026) IF: 4.7Products Cited: RPMI-1640 Complete Medium (10)
